||Recombinant Mouse Ebi3&Il27 (Accession # O35228 (EBI3) & Q8K3I6 (p28)), fused with , was produced in Mouse myeloma cell line, NS0-derived.
|Predicted N Terminal:
||Lyophilized from a 0.2 µm filtered solution in PBS and CHAPS with BSA as a carrier protein.
||Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Bender H. et al. (2009) Hepatology 50:585.The ED50 for this effect is typically 0.6-6 ng/mL.
||Recombinant Mouse Ebi3&Il27 has a calculated MW of 48.7 kDa. In SDS-PAGE migrates as 60-65 kDa, reducing conditions.
||>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).